243 related articles for article (PubMed ID: 27737495)
1. A countermeasure development pipeline.
MacRae CA; Boss G; Brenner M; Gerszten RE; Mahon S; Peterson RT
Ann N Y Acad Sci; 2016 Aug; 1378(1):58-67. PubMed ID: 27737495
[TBL] [Abstract][Full Text] [Related]
2. Metabolomics in alcohol research and drug development.
Harrigan GG; Maguire G; Boros L
Alcohol Res Health; 2008; 31(1):26-35. PubMed ID: 23584749
[TBL] [Abstract][Full Text] [Related]
3. An NIH National Center for Advancing Translational Sciences: is a focus on drug discovery the best option?
Littman BH
Nat Rev Drug Discov; 2011 Jun; 10(6):471. PubMed ID: 21597471
[No Abstract] [Full Text] [Related]
4. Mining for therapeutic gold.
Collins FS
Nat Rev Drug Discov; 2011 Jun; 10(6):397. PubMed ID: 21629277
[TBL] [Abstract][Full Text] [Related]
5. Supporting Fundamental Chemical Toxicology Research To Inform Medical Countermeasure Developments: The National Institutes of Health Chemical Countermeasures Research Program.
Yeung DT; Harper JR; Platoff GE
Chem Res Toxicol; 2020 Apr; 33(4):855-859. PubMed ID: 32196324
[TBL] [Abstract][Full Text] [Related]
6. Could pharma open its drug freezers?
Mullard A
Nat Rev Drug Discov; 2011 Jun; 10(6):399-400. PubMed ID: 21629278
[No Abstract] [Full Text] [Related]
7. Clinical research in OA--the NIH Osteoarthritis Initiative.
Lester G
J Musculoskelet Neuronal Interact; 2008; 8(4):313-4. PubMed ID: 19147953
[No Abstract] [Full Text] [Related]
8. NIH Roadmap for Medical Research.
Kantor LW
Alcohol Res Health; 2008; 31(1):12-3. PubMed ID: 23584747
[TBL] [Abstract][Full Text] [Related]
9. New NIH center broadens scope of translational research.
Jenks S
J Natl Cancer Inst; 2012 May; 104(10):728-31. PubMed ID: 22544941
[No Abstract] [Full Text] [Related]
10. Sustaining the engine of U.S. biomedical discovery.
Heinig SJ; Krakower JY; Dickler HB; Korn D
N Engl J Med; 2007 Sep; 357(10):1042-7. PubMed ID: 17804852
[No Abstract] [Full Text] [Related]
11. Engineering breakthrough research: high-tech has it hardwired.
Zusman EE
Neurosurgery; 2011 Jun; 68(6):N17-9. PubMed ID: 21778944
[No Abstract] [Full Text] [Related]
12. Opinion: NIH must support broadly focused basic research.
Spradling AC
Proc Natl Acad Sci U S A; 2016 Jul; 113(30):8340-2. PubMed ID: 27466401
[No Abstract] [Full Text] [Related]
13. The emergence of metabolomics as a key discipline in the drug discovery process.
Fillet M; Frédérich M
Drug Discov Today Technol; 2015 Jun; 13():19-24. PubMed ID: 26190679
[TBL] [Abstract][Full Text] [Related]
14. Embrace change.
Nature; 2011 Mar; 471(7337):135. PubMed ID: 21390083
[No Abstract] [Full Text] [Related]
15. Drug development needs a new brand of science.
Fitzgerald G
Nature; 2010 Dec; 468(7326):869. PubMed ID: 21164436
[No Abstract] [Full Text] [Related]
16. Peer review at National Institutes of Health: small steps forward.
Johnston SC; Hauser SL
Ann Neurol; 2008 Nov; 64(5):A15-7. PubMed ID: 19067350
[No Abstract] [Full Text] [Related]
17. Research policy: the map man.
Wadman M
Nature; 2007 Jul; 448(7152):406-7. PubMed ID: 17653164
[No Abstract] [Full Text] [Related]
18. National Institutes of Health Dermatology Funding Trends 2015-2019.
Price KN; Collier EK; Atluri S; Hsiao JL; Shi VY
J Invest Dermatol; 2021 Jan; 141(1):232-235. PubMed ID: 32464149
[No Abstract] [Full Text] [Related]
19. Grand challenges in neurology: a global call for action.
Lancet Neurol; 2011 Sep; 10(9):773. PubMed ID: 21849160
[No Abstract] [Full Text] [Related]
20. Partnering for therapeutics discovery.
Colvis CM; Devaney S; Brady LS; Hudson KL
Clin Pharmacol Ther; 2013 Jan; 93(1):24-5. PubMed ID: 23187876
[No Abstract] [Full Text] [Related]
[Next] [New Search]
